COMBINATIONS, HAVING IMMUNOSUPPRESSIVE EFFECTS, CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIENE A4 HYDROLASE INHIBITOR

摘要

Treatment with a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolaseinhibitor is described as being useful in reducing recipient rejection oftransplanted organs and for treatment of autoimmune diseases.